Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

NCT03222089 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped Another study enrolling the similar group of patient are ongoing

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: Levoleucovorin
DRUG: 5-FU
DRUG: GM-CSF
DRUG: IL-2

Sponsor

Fujian Cancer Hospital